COVID-19: Gilead To Fill Remdesivir Supply Gap In EU
Coronavirus Reignites Compulsory Licensing Debate
As the US firm prepares to ramp up production of the antiviral for use in coronavirus patients, a debate is growing over whether changes could be made to EU rules that prevent the importation of generic drugs produced under a compulsory license.
